Asia News
Filter News
Found 31,998 articles
-
Teva Pharmaceuticals is expecting big things from its generic EpiPen. The company snagged approval for its generic version of Mylan’s EpiPen Auto-Injector in August 2018.
-
Japanese Researchers Will Use Stem Cells to Treat Spinal Cord Injuries in Groundbreaking Clinical...
2/19/2019
Four patients with spinal cord injuries will receive nerve cells made from induce pluripotent stem cells in hopes of regaining sensation and mobility lost as a result of the injury. -
Could a drug used to treat tapeworms be effective at treating a type of cancer? Researchers in Singapore think they are on the right track in demonstrating just that.
-
Cerveau Technologies, Inc. and Institut de Radiofarmacia Aplicada de Barcelona, S.L. Announce Agreement to Manufacture Investigational Tau Ligand, [18F]MK-6240
2/19/2019
This week Institut de Radiofarmacia Aplicada de Barcelona, S.L., a leading producer of imaging biomarkers for use in clinical research, has signed an agreement that grants the company the right to manufacture [18F]MK-6240, a next generation investigational Positron Emission Tomography imaging agent.
-
Nobel Prize Winner Professor Aaron Ciechanover appointed senior member on the advisory committee of Panaxia Pharmaceutical
2/19/2019
Dr. Dadi Segal, CEO and founder of Panaxia: "The entrance of a world-renowned scientist places Panaxia Pharmaceutical as a leading contender in the industry, and acts as a vote of confidence in the company's capabilities."
-
ReWalk Announces 510k FDA Submission for ReStore™ Exo-Suit for Stroke Rehabilitation
2/19/2019
Innovation in robotic rehabilitation technology will provide the first-of-its-kind medical device to rehab clinics nationwide, to treat the millions of patients with lower limb disability due to stroke
-
Shinkowa Pharmaceutical Co., Ltd. Receives an Interim Report of Clinical Research on Oral Intake of NMN (24 Weeks) and Starts Cooperation with Academic Research Institutions
2/19/2019
We are the company that will achieve productive aging worldwide with advancing biomedical science
-
Intec Pharma Reports Positive Results from Pharmacokinetic Study of Accordion Pill™ Carbidopa/Levodopa 50/500 mg Dosed Three Times Daily
2/19/2019
AP-CD/LD met primary endpoint of reducing plasma levodopa variability compared to standard oral CD/LD with statistical significance
-
CollPlant Announces Approval of Its rhCollagen Manufacturing Facility by European Union Notified Body
2/19/2019
Facility produces proprietary rhCollagen used for BioInks in 3D bioprinting of organs and for dermal fillers
-
Ben-Gurion University Introduces Novel AI Platform for Monitoring and Predicting ALS Progression
2/19/2019
Precision medicine platform assists in finding markers for personalized patient care and improves drug development of neurodegenerative diseases
-
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results
2/19/2019
Global Cord Blood Corporation announced that it plans to release its unaudited financial results for the third quarter and first nine months of fiscal year 2019 on Monday, February 25, 2019, after the market close.
-
LAIX Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on Wednesday, February 27, 2019
2/19/2019
LAIX Inc. announced that it will report its fourth quarter and full year 2018 unaudited financial results on Wednesday, February 27, 2019, before the open of the U.S. markets.
-
Mumbai-based Glenmark Pharmaceuticals is spinning off its innovation business into a standalone company based in the United States. The new business will have its own chief executive officer and board of directors.
-
SIRIO Pharma receives Sports Nutrition Production License approval, potentially opening up sizable sports product growth in China
2/18/2019
Sirio Pharma Co. Ltd (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – today announces that it has been granted SC (production license) of sports nutrition food in China.
-
Hummingbird Bioscience Announces Nobel Laureate Dr. James Allison and Dr. Padmanee Sharma Join its Scientific Advisory Board
2/18/2019
Hummingbird Bioscience, a systems-biology enabled biotech company focused on the discovery and development of novel cancer therapeutics, today announced James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D., have joined its Scientific Advisory Board.
-
Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology
2/18/2019
The Automation of Neonatal Critical Congenital Heart Disease (CCHD) Screening Across More Than 370 Healthcare Facilities Is Expected to Improve the Process of Screening More Than 550,000 Newborns Annually by 2020
-
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients
2/18/2019
Chipscreen Biosciences announce the signing of a collaboration agreement with Innovent Biologics, Inc. to evaluate the safety and tolerability of Chipscreen's Chidamide and Innovent's Sintilimab in combination with an anti-VEGF monoclonal antibody IBI305 in patients with advanced colorectal carcinoma.
-
Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients
2/18/2019
Innovent Biologics, Inc. announced the signing of a collaboration agreement with Shenzhen Chipscreen Biosciences Co., Ltd.
-
New Early Breast Cancer Drug To Be Made Available In Singapore Via Special Access Program
2/17/2019
A NEW breast cancer drug shown to significantly reduce the risk of cancer recurrence is being made available to women in Singapore via a Special Access Program.
-
Prime Hospital’s Antibiotics Stewardship Program selected to be presented at ECCMID 2019
2/16/2019
The hospital’s ASP has been designed to regulate the overuse of antibiotics